5,6,8,9,11,12,14,15-OCTAHYDRO-2-(5,6,8,9,11,12,14,15-OCTAHYDRO-1,3-DITHIOLO(4,5-K)(1,4,7,10,13)TRIOXADITHIACYCLOPENTADECIN-2-YLIDENE)-1,3-DITHIOLO(4,5-K)(1,4,7,10,13)TRIOXADITHIACYCLOPENTADECIN
UNII 36KGN8MC9B
Substance Identification & Data
This profile provides standardized clinical and technical data for 5,6,8,9,11,12,14,15-octahydro-2-(5,6,8,9,11,12,14,15-octahydro-1,3-dithiolo(4,5-k)(1,4,7,10,13)trioxadithiacyclopentadecin-2-ylidene)-1,3-dithiolo(4,5-k)(1,4,7,10,13)trioxadithiacyclopentadecin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 36KGN8MC9B.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 98449-88-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H32O6S8 XCTBVNZZLKEVQX-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5,6,8,9,11,12,14,15-octahydro-2-(5,6,8,9,11,12,14,15-octahydro-1,3-dithiolo(4,5-k)(1,4,7,10,13)trioxadithiacyclopentadecin-2-ylidene)-1,3-dithiolo(4,5-k)(1,4,7,10,13)trioxadithiacyclopentadecin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.